Vertex Pharmaceuticals (VRTX) Total Costs & Expenses & History | Stock Alarm

Demo Sign up Log In

Vertex Pharmaceuticals · Total Costs & Expenses

VRTX Total Costs & Expenses

Latest reported$7.75Bperiod endingJun 30, 2026

VRTX Total Costs & Expenses ($6.40M → $7.75B)

Annual Total Costs & Expenses

High-resolution chart · PNG

VRTX total costs & expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Costs & Expenses — Annual fiscal periods (USD)
Period ending	Total Costs & Expenses (USD)
Dec 31, 2025	7,313,900,000
Dec 31, 2024	11,253,000,000
Dec 31, 2023	6,037,200,000
Dec 31, 2022	4,623,300,000
Dec 31, 2021	4,792,300,000
Dec 31, 2020	3,349,400,000
Dec 31, 2019	2,960,796,000
Dec 31, 2018	2,383,631,000
Dec 31, 2017	2,095,823,000
Dec 31, 2016	1,690,979,000
Dec 31, 2015	1,498,792,000
Dec 31, 2014	1,221,902,000
Dec 31, 2013	1,411,402,000
Dec 31, 2012	1,522,866,000
Dec 31, 2011	1,188,932,000
Dec 31, 2010	837,946,000
Dec 31, 2009	694,184,000
Dec 31, 2008	633,888,000
Dec 31, 2007	611,685,000
Dec 31, 2006	441,743,000
Dec 31, 2005	302,628,000
Dec 31, 2004	239,950,000
Dec 31, 2003	241,844,000
Dec 31, 2002	280,689,000
Dec 31, 2001	235,639,000
Dec 31, 2000	116,809,000
Dec 31, 1999	101,200,000
Dec 31, 1998	76,800,000
Dec 31, 1997	63,000,000
Dec 31, 1996	43,100,000
Dec 31, 1995	48,600,000
Dec 31, 1994	40,300,000
Dec 31, 1993	26,700,000
Dec 31, 1992	13,800,000
Dec 31, 1991	8,800,000
Dec 31, 1990	6,400,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.